Figure 5.The survival analysis of patients who received HSOS for different durations (less than 3 months vs. more than 3 months).
Figure 5 — A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II–III NSCLC | Aging
